1007-99-4

Basic information

• Product Name: 2-AMINO-4-CHLORO-6-HYDROXY-5-NITROPYRIMIDINE
• Synonyms: ACHNP;AKOS 92816;2-AMINO-4-CHLORO-5-NITRO-6-HYDROXYPYRIMIDINE;2-AMINO-4-CHLORO-6-HYDROXY-5-NITROPYRIMIDINE;2-Amino-6-chloro-5-nitropyrimidin-4-ol;2-Amino-6-chloro-5-nitropyrimidin-4(5H)-one;2-amino-6-chloro-5-nitro-1H-pyrimidin-4-one;2-azanyl-6-chloro-5-nitro-1H-pyrimidin-4-one
• CAS NO: 1007-99-4
• Molecular Formula: C₄H₃ClN₄O₃
• Molecular Weight: 190.54
• Mol File: 1007-99-4.mol
• Article Data: 18

Chemical Properties

• Melting Point: >350 °C
• Boiling Point: 268.2 °C at 760 mmHg
• Flash Point: 116 °C
• Appearance: /
• Density: 2.2 g/cm³
• Vapor Pressure: 1.67E-06mmHg at 25°C
• Refractive Index: 1.816
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• PKA: 4?+-.0.50(Predicted)
• CAS DataBase Reference: 2-AMINO-4-CHLORO-6-HYDROXY-5-NITROPYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-4-CHLORO-6-HYDROXY-5-NITROPYRIMIDINE(1007-99-4)
• EPA Substance Registry System: 2-AMINO-4-CHLORO-6-HYDROXY-5-NITROPYRIMIDINE(1007-99-4)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 1007-99-4(Hazardous Substances Data)

Usage

General Description

2-AMINO-4-CHLORO-6-HYDROXY-5-NITROPYRIMIDINE is a chemical compound with the molecular formula C5H3ClN4O3. It is a pyrimidine derivative that contains an amino group, a chloro group, a hydroxy group, and a nitro group. 2-AMINO-4-CHLORO-6-HYDROXY-5-NITROPYRIMIDINE is used in the pharmaceutical industry for its antibacterial properties and is commonly found in antimicrobial formulations. It functions by inhibiting the growth and reproduction of bacteria, making it an effective ingredient in various medicines and healthcare products. Its structure and properties make it a valuable tool for developing new drugs and medicines for bacterial infections.

InChI:InChI=1/C4H3ClN4O3/c5-2-1(9(11)12)3(10)8-4(6)7-2/h1H,(H2,6,8,10)

Upstream product

• 1194-21-4 2-amino-6-chloro-4-pyrimidinol 
• 1194-21-4 6-chloroisocytosine 
• 1194-21-4 2-amino-6-chloro-1H-pyrimidin-4-one 

Downstream Products

• 883-10-3 2-amino-6-(2'-hydroxyethyl)amino-5-nitropyrimidin-4(3H)-one 
• 833480-26-5 2-amino-6-[5-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-(tert-butyl-dimethyl-silanyloxy)-tetrahydro-furan-2-ylamino]-5-nitro-3H-pyrimidin-4-one 
• 367518-77-2 6-[2’-deoxy-3’-O-dimethoxytrityl-5’-O-tert-butyl(dimethyl)silyl-α,β-D-ribofuranose-1’-yl]amino-2-amino-5-nitropyrimidine-3H-4-one 
• 1196886-23-3 ethyl 2-(2-amino-5-nitro-6-oxo-1,6-dihydropyrimidin-4-yl)-2-cyano-3-(3,4-dimethoxyphenyl)propanoate 
• 1123800-12-3 2-amino-5-nitro-6-phenylsulfanyl-1H-pyrimidin-4-one 
• 1086338-99-9 2-amino-6-(N-methylanilino)-5-nitropyrimidin-4(3H)-one 
• 1000417-71-9 2-amino-6-[4-(4-methylpiperidin-1-sulfonyl)phenylamino]-5-nitro-3H-pyrimidin-4-one 
• 1000417-70-8 2-amino-5-nitro-6-[4-(piperidin-1-sulfonyl)phenylamino]-3H-pyrimidin-4-one 
• 1000417-77-5 2-amino-6-[2-methoxy-4-(4-methylpiperidin-1-sulfonyl)phenylamino]-5-nitro-3H-pyrimidin-4-one 
• 1000417-76-4 2-amino-6-[2-methoxy-4-(piperidin-1-sulfonyl)phenylamino]-5-nitro-3H-pyrimidin-4-one 
• 1000417-75-3 2-amino-6-[2-chloro-4-(4-methylpiperidin-1-sulfonyl)phenylamino]-5-nitro-3H-pyrimidin-4-one 
• 1000417-74-2 2-amino-6-[2-chloro-4-(piperidin-1-sulfonyl)phenylamino]-5-nitro-3H-pyrimidin-4-one 
• 1000417-73-1 2-amino-6-[2-fluoro-4-(4-methylpiperidin-1-sulfonyl)phenylamino]-5-nitro-3H-pyrimidin-4-one 
• 1000417-72-0 2-amino-6-[2-fluoro-4-(piperidin-1-sulfonyl)phenylamino]-5-nitro-3H-pyrimidin-4-one 

Relevant articles and documents

Synthetic spectroscopic models related to coenzymes and base pairs. II. Evidence for intramolecular base-base interactions in dinucleotide analog.

-

Synthesis and structure-activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors

The synthesis of a novel series of guanine analogues is reported. The compounds have been assessed in vitro and some analogues have been found to be inhibitors of phosphodiesterase type 7 (PDE7).

-

-

Microwave-assisted synthesis and docking studies of phenylureas as candidates for the drug design against the biological warfare agent Yersinia pestis

Background: Bubonic plague is amongst the diseases with the highest potential for being used in biological warfare attacks today. Introduction: This disease, caused by the bacterium Yersina pestis, is highly infectious and can achieve 100% of fatal victims when in its most dangerous form. Besides, there is no effective vac-cine, and the chemotherapy available today against plague is ineffective if not administered at the beginning of the infection. Willing to contribute for changing this reality we propose here new phe-nylureas as candidates for the drug design against plague meant to target the enzyme dihydrofolate reductase from Y. pestis (YpDHFR). Methods: Seven phenylureas, four of them new, were synthesized, following synthetic routes adapted from procedures available in the literature, and using microwave irradiation. After, they were submitted to docking studies inside YpDHFR and human DHFR (HssDHFR) in order to check their potential as selective inhibitors. Results & Conclusion: Our results revealed four new phenylureas and a new synthetic route for this kind of molecule using microwave irradiation. Also, our docking studies pointed to two of the phe-nylureas as selective inhibitors of YpDHFR and, therefore, candidates for the design of new drugs against plague.

TRIAZOLO [4, 5-D] PYRAMIDINE DERIVATIVES AND THEIR USE AS PURINE RECEPTOR ANTAGONISTS

Compounds of formula (I) that are capable of acting as purine receptor antagonists, pharmaceutical compositions including the compounds, and methods of making the compounds, are. disclosed. The compounds and compositions can be used in treating or preventing disorders related to purine receptor hyperfunctioning.